Furthermore, animal studies indicate that lung antigen-presenting cancer-associated fibroblasts (apCAFs) can directly activate CD4+T cells via MHC II presentation and secrete C1q, This secretion inhibits CD4+T cell apoptosis and bolsters anti-tumor immune responses (151). This evidence concerns the gene CD4 and cancer.